HSBC Holdings’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-100,904
Closed -$11.6M – 3198
2024
Q3
$11.6M Sell
100,904
-114,058
-53% -$12.9M 0.01% 877
2024
Q2
$23M Buy
+214,962
New +$21.6M 0.01% 644
2023
Q1
– Sell
-73,350
Closed -$6.63M – 2931
2022
Q4
$6.63M Buy
+73,350
New +$6.18M 0.01% 1136
2021
Q4
– Sell
-5,458
Closed -$446K – 3323
2021
Q3
$446K Buy
+5,458
New +$491K ﹤0.01% 2324
2019
Q2
– Sell
-2,911
Closed -$251K – 2812
2019
Q1
$251K Buy
+2,911
New +$234K ﹤0.01% 2437
2018
Q2
– Sell
-3,077
Closed -$223K – 2668
2018
Q1
$223K Sell
3,077
-2,426
-44% -$185K ﹤0.01% 2347
2017
Q4
$414K Buy
5,503
+1,266
+30% +$95.5K ﹤0.01% 1573
2017
Q3
$326K Sell
4,237
-175
-4% -$13.2K ﹤0.01% 1906
2017
Q2
$330K Sell
4,412
-11,753
-73% -$833K ﹤0.01% 1828
2017
Q1
$1.07M Buy
16,165
+2,937
+22% +$196K ﹤0.01% 1392
2016
Q4
$863K Buy
13,228
+9,987
+308% +$648K ﹤0.01% 1485
2016
Q3
$230K Buy
3,241
+3,125
+2,694% +$228K ﹤0.01% 1865
2016
Q2
$9K Sell
116
-3,257
-97% -$225K ﹤0.01% 2033
2016
Q1
$219K Sell
3,373
-1,280
-28% -$87.1K ﹤0.01% 1890
2015
Q4
$359K Buy
+4,653
New +$370K ﹤0.01% 1799
2014
Q1
– Sell
-6,886
Closed -$497K – 1781
2013
Q4
$497K Buy
+6,886
New +$479K ﹤0.01% 1422
2013
Q3
– Sell
-3,847
Closed -$244K – 1744
2013
Q2
$244K Buy
+3,847
New +$250K ﹤0.01% 1391

Other funds holding NVS

HSBC Holdings's NVS Position: Q4 2024 in Review

HSBC Holdings sold out of Novartis (NVS) in Q4 2024, closing a stake of 100,904 shares — an estimated $11.6M sold.

HSBC Holdings first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $23M in Q2 2024. 1,342 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • HSBC Holdings reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • HSBC Holdings sold 100,904 Novartis shares in Q4 2024, an estimated $11.6M.
  • HSBC Holdings first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
  • HSBC Holdings's Novartis position peaked at $23M in Q2 2024.
  • 1,342 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on HSBC Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.